Protein modification, otubain
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | yes | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 4 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4HXL8
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0016579 | protein deubiquitination | 6 | 6 |
GO:0019538 | protein metabolic process | 3 | 10 |
GO:0036211 | protein modification process | 4 | 6 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0043412 | macromolecule modification | 4 | 6 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0070646 | protein modification by small protein removal | 5 | 6 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 6 |
GO:0071108 | protein K48-linked deubiquitination | 7 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 10 |
GO:0004843 | cysteine-type deubiquitinase activity | 5 | 10 |
GO:0005488 | binding | 1 | 4 |
GO:0005515 | protein binding | 2 | 4 |
GO:0008233 | peptidase activity | 3 | 10 |
GO:0008234 | cysteine-type peptidase activity | 4 | 10 |
GO:0016787 | hydrolase activity | 2 | 10 |
GO:0019783 | ubiquitin-like protein peptidase activity | 4 | 10 |
GO:0032182 | ubiquitin-like protein binding | 3 | 4 |
GO:0043130 | ubiquitin binding | 4 | 4 |
GO:0101005 | deubiquitinase activity | 5 | 10 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 125 | 129 | PF00656 | 0.385 |
CLV_C14_Caspase3-7 | 243 | 247 | PF00656 | 0.489 |
CLV_C14_Caspase3-7 | 75 | 79 | PF00656 | 0.385 |
CLV_NRD_NRD_1 | 18 | 20 | PF00675 | 0.517 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.309 |
CLV_PCSK_KEX2_1 | 18 | 20 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.405 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.693 |
DOC_MAPK_MEF2A_6 | 216 | 224 | PF00069 | 0.309 |
DOC_PP2B_LxvP_1 | 256 | 259 | PF13499 | 0.425 |
DOC_PP2B_LxvP_1 | 29 | 32 | PF13499 | 0.432 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.336 |
DOC_WW_Pin1_4 | 57 | 62 | PF00397 | 0.408 |
LIG_14-3-3_CanoR_1 | 151 | 160 | PF00244 | 0.401 |
LIG_BRCT_BRCA1_1 | 115 | 119 | PF00533 | 0.385 |
LIG_Clathr_ClatBox_1 | 121 | 125 | PF01394 | 0.336 |
LIG_DLG_GKlike_1 | 111 | 118 | PF00625 | 0.385 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.373 |
LIG_FHA_1 | 51 | 57 | PF00498 | 0.421 |
LIG_FHA_2 | 188 | 194 | PF00498 | 0.415 |
LIG_LIR_Gen_1 | 103 | 108 | PF02991 | 0.440 |
LIG_LIR_Gen_1 | 68 | 74 | PF02991 | 0.324 |
LIG_LIR_LC3C_4 | 248 | 253 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 103 | 107 | PF02991 | 0.387 |
LIG_LIR_Nem_3 | 116 | 122 | PF02991 | 0.257 |
LIG_LIR_Nem_3 | 176 | 182 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 68 | 72 | PF02991 | 0.342 |
LIG_LYPXL_yS_3 | 24 | 27 | PF13949 | 0.336 |
LIG_Pex14_2 | 122 | 126 | PF04695 | 0.309 |
LIG_Pex14_2 | 214 | 218 | PF04695 | 0.333 |
LIG_RPA_C_Fungi | 106 | 118 | PF08784 | 0.385 |
LIG_SH2_CRK | 188 | 192 | PF00017 | 0.425 |
LIG_SH2_CRK | 262 | 266 | PF00017 | 0.309 |
LIG_SH2_PTP2 | 104 | 107 | PF00017 | 0.385 |
LIG_SH2_SRC | 166 | 169 | PF00017 | 0.436 |
LIG_SH2_STAT3 | 49 | 52 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 104 | 107 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.315 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 171 | 174 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.425 |
LIG_SH2_STAT5 | 49 | 52 | PF00017 | 0.425 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.425 |
LIG_SUMO_SIM_anti_2 | 103 | 110 | PF11976 | 0.385 |
LIG_SUMO_SIM_anti_2 | 198 | 203 | PF11976 | 0.403 |
LIG_SUMO_SIM_par_1 | 25 | 30 | PF11976 | 0.381 |
LIG_TRAF2_1 | 110 | 113 | PF00917 | 0.336 |
LIG_TYR_ITIM | 186 | 191 | PF00017 | 0.309 |
MOD_CK1_1 | 60 | 66 | PF00069 | 0.385 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.336 |
MOD_GlcNHglycan | 168 | 171 | PF01048 | 0.408 |
MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.451 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.369 |
MOD_GSK3_1 | 57 | 64 | PF00069 | 0.405 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.474 |
MOD_N-GLC_1 | 233 | 238 | PF02516 | 0.399 |
MOD_N-GLC_2 | 219 | 221 | PF02516 | 0.425 |
MOD_NEK2_1 | 27 | 32 | PF00069 | 0.345 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.458 |
MOD_NEK2_2 | 187 | 192 | PF00069 | 0.398 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.393 |
MOD_Plk_1 | 111 | 117 | PF00069 | 0.385 |
MOD_Plk_1 | 138 | 144 | PF00069 | 0.385 |
MOD_Plk_1 | 236 | 242 | PF00069 | 0.425 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.330 |
MOD_Plk_4 | 52 | 58 | PF00069 | 0.338 |
MOD_ProDKin_1 | 57 | 63 | PF00069 | 0.408 |
TRG_DiLeu_BaEn_1 | 103 | 108 | PF01217 | 0.385 |
TRG_DiLeu_BaEn_3 | 177 | 183 | PF01217 | 0.336 |
TRG_DiLeu_BaLyEn_6 | 22 | 27 | PF01217 | 0.490 |
TRG_ENDOCYTIC_2 | 104 | 107 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.425 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.385 |
TRG_ENDOCYTIC_2 | 188 | 191 | PF00928 | 0.273 |
TRG_ENDOCYTIC_2 | 24 | 27 | PF00928 | 0.457 |
TRG_ENDOCYTIC_2 | 262 | 265 | PF00928 | 0.309 |
TRG_ER_diArg_1 | 17 | 19 | PF00400 | 0.475 |
TRG_NES_CRM1_1 | 113 | 125 | PF08389 | 0.336 |
TRG_Pf-PMV_PEXEL_1 | 151 | 155 | PF00026 | 0.494 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1P6 | Leptomonas seymouri | 63% | 99% |
A0A0S4J6F9 | Bodo saltans | 33% | 100% |
A0A1X0NSN1 | Trypanosomatidae | 36% | 100% |
A0A3S7WUP0 | Leishmania donovani | 100% | 100% |
A0A422NBK6 | Trypanosoma rangeli | 40% | 100% |
A4H997 | Leishmania braziliensis | 83% | 100% |
A8XDJ2 | Caenorhabditis briggsae | 33% | 94% |
B2RYG6 | Rattus norvegicus | 33% | 100% |
C9ZPB3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9ARB4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4QE49 | Leishmania major | 98% | 100% |
Q7TQI3 | Mus musculus | 33% | 100% |
Q8LG98 | Arabidopsis thaliana | 31% | 88% |
Q96DC9 | Homo sapiens | 26% | 100% |
Q96FW1 | Homo sapiens | 33% | 100% |
Q9CQX0 | Mus musculus | 28% | 100% |
Q9VL00 | Drosophila melanogaster | 28% | 100% |
Q9XVR6 | Caenorhabditis elegans | 29% | 95% |
V5BNY1 | Trypanosoma cruzi | 39% | 100% |